What is Shenzhen Hepalink Pharmaceutical Group Co Price-to-Operating-Cash-Flow?
As of today (2024-06-02), Shenzhen Hepalink Pharmaceutical Group Co's share price is HK$3.57.
Shenzhen Hepalink Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was HK$1.10. Hence, Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Ratio for today is 3.24.
The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:09989'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.58 Med: 39.81 Max: 853.33
Current: 9.79
During the past 13 years, Shenzhen Hepalink Pharmaceutical Group Co's highest Price-to-Operating-Cash-Flow Ratio was 853.33. The lowest was 8.58. And the median was 39.81.
Shenzhen Hepalink Pharmaceutical Group Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was HK$0.65.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was HK$1.10.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 113.10% per year.
During the past 13 years, Shenzhen Hepalink Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 113.10% per year. The lowest was -41.40% per year. And the median was -5.70% per year.
Shenzhen Hepalink Pharmaceutical Group Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Hepalink Pharmaceutical Group Co Price-to-Operating-Cash-Flow Chart
|
Shenzhen Hepalink Pharmaceutical Group Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
615.00 |
- |
- |
43.28 |
|
Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
43.28 |
8.22 |
Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.
Shenzhen Hepalink Pharmaceutical Group Co Price-to-Operating-Cash-Flow Calculation
Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 3.57 | / | 1.103 |
| = | 3.24 |
Shenzhen Hepalink Pharmaceutical Group Co's Share Price of today is HK$3.57.
Shenzhen Hepalink Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$1.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Business Description
Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.
Executives
Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09989 has been successfully added to your